Imatinib: Treatment for myeloproliferative diseases

Healthcare professionals recommend the use of Imatinib for the treatment of Aggressive Systemic Mastocytosis, Dermatofibrosarcoma Protuberans, Kit+ Gastrointestinal Stromal Tumors, Kit+ Gastrointestinal Stromal Tumors and Pediatric patients with Ph+ Acute Lymphoblastic Leukemia. The active ingredient in the medicine is Imatinib mesylate, and the inactive ingredients are colloidal silicon dioxide, crospovidone, hydroxypropyl methylcellulose, magnesium stearate, and microcrystalline cellulose. This medicine is found in 100 mg and 400 mg tablets for oral administration. Imatinib 400 mg is readily available in India with numerous generic medicine suppliers. The Indian Pharma is a certified generic medicine supplier, supplying medicines for more than 7 years.

Category: Business > Healthcare Upgrade Options